<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03964077</url>
  </required_header>
  <id_info>
    <org_study_id>GaziosmanpasaTREH6</org_study_id>
    <nct_id>NCT03964077</nct_id>
  </id_info>
  <brief_title>Turkish Version of the Neurogenic Bladder Symptom Score Questionnaire: a Cross-cultural Adaptation, Reliability and Validity Study</brief_title>
  <official_title>Turkish Version of the Neurogenic Bladder Symptom Score Questionnaire: a Cross-cultural Adaptation, Reliability and Validity Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaziosmanpasa Taksim Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gaziosmanpasa Taksim Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Turkish version of the Neurogenic Bladder Symptom Score questionnaire: a cross-cultural
      adaptation, reliability and validity study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Turkish version of the Neurogenic Bladder Symptom Score questionnaire: a cross-cultural
      adaptation, reliability and validity study in spinal cord patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Actual">January 27, 2020</completion_date>
  <primary_completion_date type="Actual">January 27, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Life quality: Short-form 36</measure>
    <time_frame>4 months</time_frame>
    <description>The quality of life of the patients will be determined using Short-form 36. The self-reported questionnaire includes 8 domains (using algorithms) (0-100 points). Higher scores show poorer quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurogenic Bladder Symptom Score Questionnaire</measure>
    <time_frame>4 months</time_frame>
    <description>Neurogenic Bladder Symptom Score Questionnaire is a 24 item self-reported questionnaire(0-74 points). The questionnaire includes 4 subgroups; incontinence (0-29 points), storage&amp;voiding (0-22 points) and consequences (0-23 points). Higher the score, the greater the severity of the symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The King's Health Questionnaire</measure>
    <time_frame>4 months</time_frame>
    <description>The King's Health Questionnaire (KHQ) is one of the most widely used for assessing QOL in patients with urinary inkontinence.The KHQ consists of two parts and 32 items [7]. The first part (21 items) contains two single-item questions that address General Health Perception and Incontinence Impact and the following seven multi-item domains: Role, Physical, and Social Limitations, Limitations in Personal Relationship, Emotional Problems, Sleep and Energy Disturbances associated with UI, and Severity Measures for UI. The second part has an 11-item Symptom Severity Scale (SSS) that assesses the presence and severity of urinary symptoms. While the entire SSS is scored from 0 (best) to 30 (worst), the minimum possible score is 0 (best health) and the maximum possible score is 100 (worst health) for all other KHQ domains.</description>
  </primary_outcome>
  <enrollment type="Actual">102</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Neurogenic Bladder Symptom Score Questionnaire</intervention_name>
    <description>Neurogenic Bladder Symptom Score Questionnaire is a self-reported 24 item questionnaire.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        70 spinal cord injury patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Spinal cord injury patients

          -  aged &gt; 18 years old

        Exclusion Criteria:

          -  spinal shock patients

          -  urinary tract operation in the last month

          -  Quality of life changes in the last month

          -  urinary tract infections in the last month

          -  bladder management changes or drug changes in the last month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mehmet Akif Guler</name>
      <address>
        <city>İstanbul</city>
        <state>İ̇stanbul</state>
        <zip>34104</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>May 22, 2019</study_first_submitted>
  <study_first_submitted_qc>May 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2019</study_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gaziosmanpasa Taksim Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Akif GÜLER</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Neurogenic Bladder</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Spinal Cord Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Urinary Bladder, Neurogenic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

